Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Electrophoresis
|
September 2, 2005
Utility of lab-on-a-chip technology for high-throughput nucleic acid and protein analysis
Paul Hawtin, Ian Hardern, Rainer Wittig, et al.
Vaccine
|
August 16, 2023
Optimal site of care for administration of extended half-life respiratory syncytial virus (RSV) antibodies to infants in the United States (US)
Christopher B Nelson, Brenna L Brady, Megan Richards, et al.
Pediatrics
|
July 21, 2025
Effectiveness of Nirsevimab Against RSV and RSV-Related Events in Infants
Amber Hsiao, John Hansen, Bruce Fireman, et al.
The Journal of Infectious Diseases
|
August 15, 2022
Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020
Jason R Gantenberg, Robertus van Aalst, Nicole Zimmerman, et al.
Chemistry & Biology
|
February 14, 2002
Hepatitis C virus NS3 protease requires its NS4A cofactor peptide for optimal binding of a boronic acid inhibitor as shown by NMR
Sharon J Archer, Daniel M Camac, Zhongren J Wu, et al.
Journal of the Pediatric Infectious Diseases Society
|
May 13, 2024
Risk Analysis of Respiratory Syncytial Virus Among Infants in the United States by Birth Month
Jason R Gantenberg, Robertus van Aalst, Monika Reddy Bhuma, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 18, 2002
CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes
Gang Luo, Mark Cunningham, Sean Kim, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Electrophoresis
|
September 2, 2005
Utility of lab-on-a-chip technology for high-throughput nucleic acid and protein analysis
Paul Hawtin, Ian Hardern, Rainer Wittig, et al.
Vaccine
|
August 16, 2023
Optimal site of care for administration of extended half-life respiratory syncytial virus (RSV) antibodies to infants in the United States (US)
Christopher B Nelson, Brenna L Brady, Megan Richards, et al.
Pediatrics
|
July 21, 2025
Effectiveness of Nirsevimab Against RSV and RSV-Related Events in Infants
Amber Hsiao, John Hansen, Bruce Fireman, et al.
The Journal of Infectious Diseases
|
August 15, 2022
Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020
Jason R Gantenberg, Robertus van Aalst, Nicole Zimmerman, et al.
Chemistry & Biology
|
February 14, 2002
Hepatitis C virus NS3 protease requires its NS4A cofactor peptide for optimal binding of a boronic acid inhibitor as shown by NMR
Sharon J Archer, Daniel M Camac, Zhongren J Wu, et al.
Journal of the Pediatric Infectious Diseases Society
|
May 13, 2024
Risk Analysis of Respiratory Syncytial Virus Among Infants in the United States by Birth Month
Jason R Gantenberg, Robertus van Aalst, Monika Reddy Bhuma, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 18, 2002
CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes
Gang Luo, Mark Cunningham, Sean Kim, et al.
Page
of 2